A phase II study of biweekly cisplatin, fixed dose rate gemcitabine and infusional 5-fluorouracil in patients with metastatic pancreatic and biliary cancers

OBJECTIVES: Combinations of gemcitabine, 5-fluorouracil (5-FU), and platinum have demonstrated improved outcomes compared with singlet chemotherapy in pancreatic and biliary cancers. This phase II study examined efficacy and safety of a novel schedule of cisplatin, fixed-dose-rate (FDR) gemcitabine...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am J Clin Oncol
Main Authors: Davis, Elizabeth J., Griffith, Kent A., Kim, Edward J., Ruch, Joshua M., McDonnell, Kevin J., Zalupski, Mark M.
Format: Artigo
Sprog:Inglês
Udgivet: 2018
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4854803/
https://ncbi.nlm.nih.gov/pubmed/26535993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000240
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker